Mitobulin 0.5mg

Mitobulin 0.5mg

Description 

Eribulin Mesylate is utilized in the therapy of metastatic bosom disease. It is utilized to treat grown-ups with bosom malignant growth that has spread to different pieces of the body, and who have just gotten other anticancer medications after the disease has spread.  Eribulin Mesylate is an enemy of malignancy prescription. It works by meddling with the microtubule structures which help the malignancy cells to isolate and increase. This squares the development cycle (cell pattern) of malignancy cells and in the long run, executes them. Eribulin Mesylate is used in the treatment of metastatic breast cancer. It is used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other anticancer medicines after cancer has spread. Eribulin Mesylate is an anti-cancer medication. It works by interfering with the microtubule structures which help the cancer cells to divide and multiply. This blocks the growth cycle (cell cycle) of cancer cells and eventually kills them